Sexual and Gender Minorities
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
Impact TherapeuticsNPOWER365 HIV care intervention
Colorado TherapeuticsSGM Communication Intervention
Clinical Trials (2)
Total enrollment: 430 patients across 2 trials
Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men
Start: Mar 2026Est. completion: Apr 2028350 patients
N/ANot Yet Recruiting
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
Start: Mar 2023Est. completion: Sep 202780 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 430 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.